DJIA 17,113.54 61.81 0.36%
NASDAQ 4,456.02 31.31 0.71%
S&P 500 1,983.53 9.90 0.50%
market minute promo

BioTime, Inc. (NYSEMKT: BTX)

2.78 0.13 (4.91%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BTX $2.78 4.91%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.66
Previous Close $2.65
Daily Range $2.66 - $2.79
52-Week Range $2.21 - $4.18
Market Cap $200.6M
P/E Ratio -3.31
Dividend (Yield) $0.00 (0.0%)
Volume 80,187
Average Daily Volume 256,256
Current FY EPS $0.00

Sector

Healthcare

Industry

Drugs

BioTime, Inc. (BTX) Description

BioTime Inc. is engaged in the business of developing blood plasma volume expanders and related products and stem cell related products and technology for diagnostic therapeutic and research use. Website: http://www.biotimeinc.com/

News & Commentary Rss Feed

Is Geron Finally Onto Something?

Here's why biotech Geron is a prime buyout target.

Sector Update: Health Care Stocks Inching Higher Late; BioTime Climbs Over 9% After Landing 14 New P

Sector Update: Health Care Stocks Inching Higher Late; BioTime Climbs Over 9% After Landing 14 New Patents

Sector Update: Health Care

BioTime Sets Its Sights On The Medical-Aesthetics Market

Live Longer, Get Richer With Patrick Cox

Live Longer, Get Richer With Patrick Cox

Advanced Cell Technology: A Key Patent Critique

BioTime Joins Advanced Cell Technology In The AMD Race

Osiris Therapeutics: Poised For Another Breakout

5 Stocks With Big Insider Buying

Stocks: Insiders Buy at Titan International, Cytokinetics, and BioTime

Plus, a purchase at Clearfield.

See More BTX News...

BTX's Top Competitors

BTX $2.78 (4.91%)
Current stock: BTX
AMGN $121.11 (1.75%)
Current stock: AMGN
GILD $89.33 (0.53%)
Current stock: GILD
BIIB $303.67 (0.39%)
Current stock: BIIB